Cancer screening in CALD communities: what works to improve rates?

Doctor speaking with Vietnamese woman

When it comes to cancer screening, people from culturally and linguistically diverse (CALD) backgrounds have lower participation rates than the general Australian population. Just under half of Australians who speak English at home are screened for bowel cancer each year, however, that number drops to one-third for Australians who speak a language other than English … Read more

Men with melanoma history face increased risk of prostate cancer

Mature aged couple putting on sunscreen at the beach

Men who have had multiple melanomas are at least twice as likely to be diagnosed with prostate cancer than men who have never had melanomas, according to new research from the Daffodil Centre using data from the Sax Institute’s 45 and Up Study. The study, published in the British Journal of Cancer, is the first … Read more

Lung cancer screening could save lives and money, study finds

Doctor running a lung CT scan for a patient

A new study from the Daffodil Centre using 45 and Up Study data has found that a targeted lung cancer screening program could not only save lives but could also be cost-effective in most cases, using a commonly accepted measure of the value of health outcomes.  The study, published in the British Journal of Cancer, … Read more

45 and Up Study participants help researchers improve cancer detection

Australian researchers have begun work on a genomics project that will use saliva collected from 45 and Up Study participants to find the best way to detect common cancers. The Australian Cancer Risk Study is a national collaborative program led by Dr Julia Steinberg and Professor Anne Cust at The Daffodil Centre, a joint venture … Read more

Health service utilisation, patterns of care, and risk factors for cancer of unknown primary (CUP) in 45 and Up Study participants

This study seeks to examine the patterns of healthcare utilisation including hospitalisations, emergency department visits, and Medicare Benefits Schedule and Pharmaceutical Benefits Scheme use prior to and after a Cancer of Unknown Primary (CUP) diagnosis, both overall and by subtype, and in relation to survival. The study will also investigate the risk factors for incident … Read more